Media

2016

27 Dec

Glenmark Pharmaceuticals receives ANDA approval for Tretinoin Capsules, 10 mg

Read More
2016

19 Dec

Glenmark Unveils its Strategic Blueprint for Transition into an Innovation‐Led Global Pharmaceutical Organization in the Next Decade

Read More
2016

12 Dec

Glenmark Launches First and Only Generic Version of Zetia® in the United States

Read More
2016

4 Nov

Glenmark announces Pre-Clinical Data Results for experimental GBR 1302-Beat Technology

Read More
2016

19 Sep

Glenmark announces Strategic Development and Global Licensing Agreement with Particle Sciences

Read More
2016

14 Sep

Glenmark Pharmaceuticals receives ANDA approval for Diclofenac Sodium Gel, 3%

Read More
2016

12 Sep

Glenmark Pharmaceuticals receives ANDA approval for Lidocaine Ointment USP, 5%

Read More
2016

6 Sep

Glenmark announces the Discovery and Initiation of IND‐enabling studies of a novel Bispecific Monoclonal Antibody targeting EGFR

Read More
2016

12 Aug

Glenmark’s consolidated revenue increased by 18% for Q1 FY 2016 – 17

Read More
2016

27 Jul

ANDA approval for  Potassium Chloride Extended-Release Tablets

Read More
2016

20 Jul

ANDA approval of Rosuvastatin Calcium Tablets

Read More
2016

24 Jun

Glenmark Pharmaceuticals receives tentative ANDA approval for  Olmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mg 

Read More
2016

24 Jun

Glenmark Pharmaceuticals receives ANDA approval for  Nystatin and Triamcinolone Acetonide Ointment USP,  100,000 units/1 mg per gram 

Read More
2016

19 May

Glenmark Pharmaceuticals receives ANDA approval for  Rufinamide Tablets USP, 200 mg and 400 mg 

Read More
2016

12 May

Glenmark’s Consolidated Revenue for Q4 FY 2015 – 16 was at Rs. 23066.76 Mn recording an increase of 29.89% 

Read More
2016

29 Apr

Glenmark Pharmaceuticals receives tentative ANDA approval for Adapalene and Benzoyl Peroxide Gel

Read More
2016

26 Apr

Glenmark Pharmaceuticals receives tentative ANDA approval for Norethindrone Acetate and Ethinyl Estradiol Tablets

Read More
2016

28 Mar

Glenmark Pharmaceuticals receives another two ANDA approvals from the U.S. FDA

Read More
2016

28 Mar

Glenmark Pharmaceuticals receives ANDA approval for Bendamustine Hydrochloride for Injection

Read More
2016

23 Mar

Glenmark Pharmaceuticals receives ANDA approval for Raloxifene Hydrochloride Tablets.

Read More
2016

18 Mar

Glenmark Pharmaceuticals receives ANDA approval for Frovatriptan Succinate Tablets

Read More
2016

14 Mar

Glenmark Pharmaceuticals receives ANDA approval for Frovatriptan Succinate Tablets

Read More
2016

24 Feb

Glenmark Pharmaceuticals receives ANDA approval for Norgestimate and Ethinyl Estradiol Tablets

Read More
2016

17 Feb

Glenmark Pharmaceuticals receives tentative ANDA approval for Azelaic Acid Gel

Read More
2016

28 Jan

Glenmark’s Consolidated Net Profit increases by 48.38% to Rs. 1703 Mn in Q3 FY 15-16

Read More
2016

21 Jan

Glenmark Pharmaceuticals receives ANDA approval for Norethindrone Acetate and Ethinyl Estradiol Tablets.

Read More
2016

21 Jan

Glenmark Pharmaceuticals receives ANDA approval for Potassium Chloride Extended-Release Capsules/

Read More
2016

8 Jan

Glenmark announces the Discovery and Initiation of IND‐enabling studies of a novel bi‐specific monoclonal antibody targeting CD38.

Read More
2016

6 Jan

Glenmark Pharmaceuticals Inc., USA receives tentative ANDA approval for Dronedarone Tablets

Read More

CMD PROFILE

With the idea of creating something unique, Glenn Saldanha took over the reins of the company and helped transform it into a global enterprise worth USD 1.1 billion with offices across 20 countries.

Download Profile

COMPANY PROFILE

Research-driven, global and integrated pharmaceutical company which is driven to meet unmet medical needs and help pave a new way for a new world.

Download Profile

For any media related queries, please email to corpcomm@glenmarkpharma.com